Enalapril attenuates ischaemic brain oedema and protects the blood-brain barrier in rats via an anti-oxidant action

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 3, 2014, Pages 220-226

  Panahpour, Hamdollah ^a   Dehghani, Gholam Abbas ^b   Bohlooli, Shahab ^a  

^a ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood brain barrier; Brain oedema; Enalapril; Glutathione; Malondialdehyde

Indexed keywords

ENALAPRIL; EVANS BLUE; GLUTATHIONE; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN EDEMA; BRAIN HOMOGENATE; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; DRUG EXTRAVASATION; DRY WEIGHT; LEFT HEMISPHERE; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; RAT; REPERFUSION INJURY; RIGHT HEMISPHERE;

BLOOD-BRAIN BARRIER; BRAIN OEDEMA; ENALAPRIL; GLUTATHIONE; MALONDIALDEHYDE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIOXIDANTS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; BRAIN ISCHEMIA; CEREBRAL ARTERIES; ENALAPRIL; GLUTATHIONE; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84896323166     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12210     Document Type: Article

References (46)

1. Schuier F, Hossmann K. Experimental brain infarcts in cats. II. Ischaemic brain oedema. Stroke 1980; 11: 593-601.
2. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci. 1999; 22: 391-7.
3. Fishman RA. Cerebrospinal Fluid in Diseases in Nervous System, 2nd edn. WB Saunders, Philadelphia. 1992.
4. Marmarou A. The pathophysiology of brain oedema and elevated intracranial pressure. Cleve. Clin. J. Med. 2004; 71(Suppl. 1): S6-8.
5. Rosenberg GA. Ischaemic brain oedema. Prog. Cardiovasc. Dis. 1999; 42: 209-16.
6. Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD, Hsu CY. Middle cerebral artery occlusion in the rat by intraluminal suture: Neurological and pathological evaluation of an improved model. Stroke 1996; 27: 1616-23.
7. Menzies SA, Betz AL, Hoff JT. Contributions of ions and albumin to the formation and resolution of ischaemic brain oedema. J. Neurosurg. 1993; 78: 257-66.
8. 2+ and BBB permeability and ultrastructure in head injury with secondary insult. J. Clin. Neurosci. 2001; 8: 561-3.
9. Gwan K, Edzes HT. Water in brain oedema. Observations by the pulsed nuclear magnetic resonance technique. Arch. Neurol. 1975; 32: 462-5.
10. Chan PH, Schmidley JW, Fishman RA, Longar SM. Brain injury, oedema, and vascular permeability changes induced by oxygen-derived free radicals. Neurology 1984; 34: 315-20.
11. Mun-Bryce S, Rosenberg GA. Matrix metalloproteinases in cerebrovascular disease. J. Cereb. Blood Flow Metab. 1998; 18: 1163-72.
12. Traystman RJ, Kirsch JR, Koehler RC. Oxygen radical mechanisms of brain injury following ischaemia and reperfusion. J. Appl. Physiol. 1991; 71: 1185-95.
13. Ajitha M, Rajnarayana K. Role of oxygen free radicals in human disease. Indian Drugs 2001; 38: 545-6.
14. Unger T, Badoer E, Ganten D, Lang R, Rettig R. Brain angiotensin: Pathways and pharmacology. Circulation 1988; 77(Suppl. I): I40-54.
15. Culman J, Blume A, Gohlke P, Unger T. The renin-angiotensin system in the brain: Possible therapeutic implications for AT(1)-receptor blockers. J. Hum. Hypertens. 2002; 16(Suppl. 3): S64-70.
16. Panahpour H, Nekouian AA, Dehghani GA. Inhibition of angiotensin-converting enzyme reduces cerebral infarction size in experimental-induced focal cerebral ischaemia in the rat. Iran. J. Med. Sci. 2007; 32: 12-7.
17. Panahpour H, Dehghani GA. Inhibition of central angiotensin-converting enzyme with enalapril protects the brain from ischaemia/reperfusion injury in normotensive rat. Daru 2010; 18: 35-40.
18. Panahpour H, Dehghani GA. Attenuation of focal cerebral ischaemic injury following post-ischaemic inhibition of angiotensin converting enzyme (ACE) activity in normotensive rat. Iran. Biomed. J. 2012; 16: 202-8.
19. Hungerhuber E, Zausinger S, Westermaier T, Plesnila N, Schmid-Elsaesser R. Simultaneous bilateral laser Doppler fluxmetry and electrophysiological recording during middle cerebral artery occlusion in rats. J. Neurosci. Methods 2006; 154: 109-15.
20. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniotomy in rats. Stroke 1989; 20: 84-91.
21. Vakili A, Nekouian AA, Dehghani GA. l-NAME and 7-nitroindazole reduces brain injuries in transient focal cerebral ischaemia in rat. Iran. J. Med. Sci. 2004; 29: 109-15.
22. Gerriets T, Stolz E, Walberer M et al. Middle cerebral artery occlusion during MR-imaging: Investigation of the hyperacute phase of stroke using a new in-bore occlusion model in rats. Brain Res. Protoc. 2004; 12: 137-43.
23. Kaya M, Kucuk M, Kalayci R, Palanduz S. Acute hyperglycemia augments blood-brain barrier damage in experimental status epilepticus. Neurosci. Res. Commun. 1999; 25: 111-9.
24. Kaya M, Kucuk M, Kalayci RB et al. Magnesium sulfate attenuates increased blood-brain barrier permeability during insulin-induced hypoglycemia in rats. Can. J. Physiol. Pharmacol. 2001; 79: 793-8.
25. Kucuk M, Kaya M, Kalayci R et al. Effects of losartan on the blood-brain barrier permeability in long-term nitric oxide blockade-induced hypertensive rats. Life Sci. 2002; 71: 937-46.
26. Ashwal S, Tone B, Tian HR, Cole DJ, Pearce WJ. Core and penumbral nitric oxide synthase activity during cerebral ischaemia and reperfusion. Stroke 1998; 29: 1037-47.
27. Lie B, Popp S, Cottrell JE, Kass IS. Lidocaine attenuates apoptosis in the ischaemic pneumbra and reduces infarct size after transient focal cerebral ischaemia in rats. Neuroscience 2004; 125: 691-701.
28. Raquel M, Lecumberri E, Ramos S, Goya L, Bravo L. Determination of malondialdehyde by high-performance liquid chromatography in serum and liver as a biomarker for oxidative stress application to a rat model for hypercholesterolemia and evaluation of the effect of diets rich in phenolic antioxidant from fruits. J. Chromatogr. B 2005; 827: 76-82.
29. Nakhostin-Roohi B, Barmaki S, Khoshkhahesh F, Bohlooli S. Effect of chronic supplementation with methylsulfonylmethane on oxidative stress following acute exercise in untrained healthy men. J. Pharm. Pharmacol. 2011; 63: 1290-4.
30. Giustarini D, Dalle-Donne I, Colombo R, Milzani A, Rossi R. An improved HPLC measurement for GSH and GSSG in human blood. Free Radic. Biol. Med. 2003; 35: 1365-72.
31. Blezer EL, Nicolay K, Bar P et al. Enalapril prevents imminent and reduces manifest cerebral oedema in stroke-prone hypertensive rats. Stroke 1998; 29: 1671-8.
32. Fu H, Hosomi N, Pelisch N et al. Therapeutic effects of postischaemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischaemia. J. Hypertens. 2011; 29: 2210-9.
33. Bulpitt CJ, Fletcher AE. Cognitive function and angiotensin-converting enzyme inhibitors in comparison with other antihypertensive drugs. J. Cardiovasc. Pharmacol. 1992; 19(Suppl. 6): S100-4.
34. Werner C, Hoffman WE, Kochs E, Rabito SF, Miletich DJ. Captopril improves neurologic outcome from incomplete cerebral ischaemia in rats. Stroke 1991; 22: 910-4.
35. Dzau VJ. Vascular renin-angiotensin system in hypertension. New insights into the mechanism of action of angiotensin converting enzyme inhibitors. Am. J. Med. 1988; 84: 4-8.
36. Haas DC, Anderson GH, Streeten DH. Role of angiotensin in lethal cerebral hypoperfusion during treatment of acute hypertension. Arch. Intern. Med. 1985; 145: 1922-4.
37. Griendling KK, Ushio-Fukai M. NADH/NADPH oxidase and vascular function. Trends Cardiovasc. Med. 1997; 7: 301-7.
38. Pueyo ME, Arnal JF, Rami J, Michel JB. Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am. J. Physiol. 1998; 274: C214-20.
39. 2 radicals in arachidonate-induced increased blood-brain barrier permeability to proteins. Am. J. Physiol. 1986; 251: H693-9.
40. Takahashi M, Fritz-Zieroth B, Ohta Y, Chikugo T. Therapeutic effects of imidapril on cerebral lesions observed by magnetic resonance imaging in malignant stroke-prone spontaneously hypertensive rats. J. Hypertens. 1994; 12: 761-8.
41. 1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats. Vascul. Pharmacol. 2006; 45: 141-7.
42. 1 antagonist. Stroke 2002; 33: 2297-303.
43. Engelhorn T, Goerike S, Doerfler A et al. The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischaemia in rats. J. Cereb. Blood Flow Metab. 2004; 24: 467-74.
44. Choi DW. Excitotoxic cell death. J. Neurobiol. 1992; 23: 1261-76.
45. Kim JH, Kim H, Kim YH, Chung WS, Suh JK, Kim SJ. Antioxidant effect of captopril and enalapril on reactive oxygen species-induced endothelial dysfunction in the rabbit abdominal aorta. Korean J. Thorac. Cardiovasc. Surg. 2013; 46: 14-21.
46. Yung LM, Wong WT, Tian XY et al. Inhibition of renin-angiotensin system reverses endothelial dysfunction and oxidative stress in estrogen deficient rats. PLoS ONE 2011; 6: e17437.